Fangyuan Li
- Biomedical Engineering top 0.5%
- Materials Chemistry top 1%
- Molecular Biology top 5%
- Biomaterials top 0.5%
- Pulmonary and Respiratory Medicine top 5%
- Topics
- Nanoplatforms for cancer theranostics (50 papers)Advanced Nanomaterials in Catalysis (38 papers)Nanoparticle-Based Drug Delivery (36 papers)
- Partner nations
- ChinaSouth KoreaNew Zealand
In The Last Decade
Fangyuan Li
183 papers receiving 7.8k citations
Hit Papers
Peers
Comparison fields: 5 of 149
- Biomedical Engineering 3.8k
- Materials Chemistry 3.1k
- Molecular Biology 2.2k
- Biomaterials 2.0k
- Pulmonary and Respiratory Medicine 757
Countries citing papers authored by Fangyuan Li
This map shows the geographic impact of Fangyuan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangyuan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangyuan Li more than expected).
Fields of papers citing papers by Fangyuan Li
This network shows the impact of papers produced by Fangyuan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangyuan Li. The network helps show where Fangyuan Li may publish in the future.
Co-authorship network of co-authors of Fangyuan Li
This figure shows the co-authorship network connecting the top 25 collaborators of Fangyuan Li. A scholar is included among the top collaborators of Fangyuan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangyuan Li. Fangyuan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 27 | |
| 5 | 10 | |
| 6 | 3 | |
| 7 | 2 | |
| 8 | 2 | |
| 9 | 23 | |
| 10 | 8 | |
| 11 | 11 | |
| 12 | 5 | |
| 13 | 24 | |
| 14 | 1 | |
| 15 | 6 | |
| 16 | 16 | |
| 17 | 6 | |
| 18 | 16 | |
| 19 | 266 | |
| 20 | 41 |
About Fangyuan Li
Fangyuan Li is a scholar working on Biomaterials, Biomedical Engineering and Materials Chemistry, having authored 191 papers that have together received 7.9k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (50 papers), Advanced Nanomaterials in Catalysis (38 papers) and Nanoparticle-Based Drug Delivery (36 papers). The work is most often cited by research in Biomaterials (2.0k citations), Biomedical Engineering (3.8k citations) and Materials Chemistry (3.1k citations). Fangyuan Li has collaborated with scholars based in China, South Korea and New Zealand. Frequent co-authors include Daishun Ling, Xi Hu, Taeghwan Hyeon, Jianqing Gao, Hongwei Liao, Fan Xia, Haibin Wu, Wei Shao, Jingxiong Lu and Zeyu Liang. Their work appears in journals such as Chemical Reviews, Journal of the American Chemical Society and Advanced Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.